S-1 · primary offering
Issued 2016
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 22 of Xenetic Biosciences, Inc.'s SEC filings and found 2 warrant series, 1 convertible, 1 ATM program, 2 shelf registrations, 1 S-1 registration and 1 completed offering on file for XBIO. The latest dilution event on file is an offering on Oct 14, 2025. Analysis updated Nov 2, 2026.
Raise routes on file: effective shelf · latest dilution event 385 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Oct 14, 2025 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2016
Proposed maximum
Shares registered
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Principal
Conversion Price
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2021
Total capacity
Remaining
Issued 2025
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z